A. Mitchell

Association between postmenopausal vulvovaginal discomfort, vaginal microbiota and mucosal inflammation: Vaginal microbiome and treatment response in postmenopausal women.

A. LaCroix, S. Proll, S. Reed, 2021, American journal of obstetrics and gynecology.

Vaginal microbiota and mucosal immune markers in women with vulvovaginal discomfort.

Noah G. Hoffman, O. Hyrien, C. Mitchell, 2020, Sexually transmitted diseases.

Impact of vaginal douching products on vaginal Lactobacillus, Escherichia coli and epithelial immune responses

C. Mitchell, A. Mitchell, A. Bergerat, 2021, Scientific Reports.

Neurogenic Bladder: Recurrent Urinary Tract Infections—Beyond Antibiotics

J. Gelfand, D. Bliss, A. Mitchell, 2018, Current Bladder Dysfunction Reports.

Can magnetic resonance imaging differentiate among transurethral bulking agent, urethral diverticulum, and periurethral cyst?

M. Harisinghani, A. Mitchell, E. De, 2019, Abdominal Radiology.

Cysteine dependence of Lactobacillus iners is a potential therapeutic target for vaginal microbiota modulation

T. Ndung’u, D. Relman, B. Woolston, 2022, Nature Microbiology.

Cysteine dependence of Lactobacillus iners is a potential therapeutic target for vaginal microbiota modulation

T. Ndung’u, D. Relman, B. Woolston, 2022, Nature Microbiology.

Cysteine dependence in Lactobacillus iners constitutes a novel therapeutic target to modify the vaginal microbiota

T. Ndung’u, B. Woolston, D. Kwon, 2021, bioRxiv.